Publication: Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
Program
KU-Authors
KU Authors
Co-Authors
Nomak, G.
Oksuzoglu, B.
Senturk, R.
Eralp, Y.
Nomak, H.
Sanyal, R.
Date
Language
Type
Embargo Status
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Source
Publisher
Elsevier
Keywords
Oncology
Citation
Has Part
Source
Annals of Oncology
Book Series Title
Edition
DOI
10.1016/j.annonc.2022.07.1876